The minnesota cancer clinical trials network (mncctn) aims to improve cancer outcomes for all minnesotans through greater access to cancer clinical trials in prevention and treatment. the minnesota cancer clinical trials network: bringing clinical trials to you . The minnesota cancer alliance is thrilled to have its members engage in this effort to accomplish objective 10 of cancer plan minnesota: increase participation in cancer treatment clinical trials. mncctn will increase public awareness about the benefits of participating in clinical trials (strategy 10.1) and create a statewide centralized.
The minnesota cancer clinical trials network (mncctn) is pleased to announce the development of a statewide educational campaign about clinical trials. the educational campaign aims to increase awareness and understanding of clinical trials for all minnesotans. The network’s newest trial, a study examining exemestane as a therapy for postmenopausal women with non small cell lung cancer, marks the first treatment trial for mncctn. this is a significant milestone for the network, its progress, and its impact on minnesotans. a treatment clinical trial studies a drug or other therapy for a disease, such. Today, access to clinical cancer trials is difficult for many minnesotans; 56 percent of state residents live more than 30 miles from a hospital or clinic that offers access to such trials. by bringing cancer clinical trials to those living in greater minnesota, the mncctn will increase access to potentially lifesaving and life changing. The state of minnesota in the us, in collaboration with the university of minnesota (u of m), has launched a new cancer clinical trials network across various locations in the state. the new minnesota cancer clinical trials network (mncctn) will be funded by the minnesota legislature as a part of the state’s discovery, research and innovation economy (mndrive), a partnership between the.
Today, access to clinical cancer trials is difficult for many minnesotans; 56 percent of state residents live more than 30 miles from a hospital or clinic that offers access to such trials. by bringing cancer clinical trials to those living in greater minnesota, the mncctn will increase access to potentially lifesaving and life changing. The state of minnesota in the us, in collaboration with the university of minnesota (u of m), has launched a new cancer clinical trials network across various locations in the state. the new minnesota cancer clinical trials network (mncctn) will be funded by the minnesota legislature as a part of the state’s discovery, research and innovation economy (mndrive), a partnership between the. New clinical trials network is funded in partnership with the state of minnesota minnesotans living in rural areas throughout greater minnesota will soon have better access to new cancer treatments and enhanced care delivery, thanks to a new state funded partnership between university of minnesota and. As part of the minnesota discovery research and innovation (mndrive) program, the medical school and masonic cancer center, university of minnesota, have been approved for a statewide cancer clinical trials network based at the university of minnesota. the minnesota cancer clinical trials network (mncctn) will bring scientific discoveries made.
New clinical trials network is funded in partnership with the state of minnesota minnesotans living in rural areas throughout greater minnesota will soon have better access to new cancer treatments and enhanced care delivery, thanks to a new state funded partnership between university of minnesota and. As part of the minnesota discovery research and innovation (mndrive) program, the medical school and masonic cancer center, university of minnesota, have been approved for a statewide cancer clinical trials network based at the university of minnesota. the minnesota cancer clinical trials network (mncctn) will bring scientific discoveries made.
Comments are closed.